Union Minister for Science and Technology, Government of India, Dr Jitendra Singh has unveiled the results of the 15th r...
A University of Sydney team have successfully created a transparent microchip with the potential to reduce the testing o...
A study led by clinician-scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s G...
Nasopharyngeal carcinoma (NPC) is a cancer type strongly associated with Epstein-Barr virus (EBV) infection. The Chinese...
A new biotech company launched on 18th June in Australia will use a world-leading technology to target cancers that are ...
To increase patient access to affordable, advanced genomic testing for cancer in Singapore, Thermo Fisher Scientific Inc...
Having previously pivoted towards medical devices more than 10 years ago, Singapore has recently seen a biotech resurgen...
Researchers at University of Auckland in New Zealand are working on an innovative way to treat an aggressive blood cance...
While in Geneva to advance Australia’s interests at the World Health Organization’s (WHO) World Health Assem...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Me...
Traditional chemotherapy often poses significant challenges, including severe side effects, damage to healthy tissue and...
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how...
Precision medicine is becoming more prevalent, with pharmaceutical companies and healthcare regimen to develop highly ta...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
A randomised, placebo-controlled clinical trial led by a collaboration between Duke-NUS Medical School, National Heart C...
OBiO Technology, a world leading contract development and manufacturing organisation (CDMO) for cell and gene thera...
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...
A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...
